50 results match your criteria: "Institute for Safe Medication Practices Canada.[Affiliation]"
Res Social Adm Pharm
January 2025
Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, Toronto, Ontario, M5T 3M6, Canada; Research & Innovation, North York General Hospital, 4001 Leslie Street, Toronto, Ontario, M2K 1E1, Canada.
Purpose: Diversion or theft of controlled substances is a recognized problem affecting healthcare systems globally. The purpose of this study was to develop a framework for identifying and characterizing system factors leading to vulnerabilities for diversion within hospitals.
Methods: We applied a qualitative framework method, which involved 1) compiling a list of critical diversion vulnerabilities through observations and proactive risk analyses in the inpatient pharmacy, emergency department and intensive care unit of two Canadian hospitals; 2) coding the vulnerabilities into deductively and inductively derived themes and subthemes; and 3) building a conceptual framework.
Am J Vet Res
September 2024
Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.
Objective: To collect medication error (ME) data during the perianesthetic period from small animal clinics.
Sample: 6 small animal general practice veterinary clinics.
Methods: Small animal general practice veterinary clinics were recruited in this prospective observational study, with staff given a presentation on medical errors and instructed on how to submit medication error reports to an online reporting system.
BMJ Open
May 2024
Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Objectives: To evaluate whether a focused, expert medication management intervention is feasible and potentially effective in preventing anticoagulation-related adverse events for patients transitioning from hospital to home.
Design: Randomised, parallel design.
Setting: Medical wards at six hospital sites in southern Ontario, Canada.
Pilot Feasibility Stud
April 2024
Pharmacy Services, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
Background: Seniors with recurrent hospitalizations who are taking multiple medications including high-risk medications are at particular risk for serious adverse medication events. We will assess whether an expert Clinical Pharmacology and Toxicology (CPT) medication management intervention during hospitalization with follow-up post-discharge and communication with circle of care is feasible and can decrease drug therapy problems amongst this group.
Methods: The design is a pragmatic pilot randomized trial with 1:1 patient-level concealed randomization with blinded outcome assessment and data analysis.
BMC Public Health
April 2023
Health Design Studio, OCAD University, Toronto, ON, M5T 1W1, Canada.
Background: In response to the rise in opioid-related deaths, communities across Ontario have developed opioid or overdose response plans to address issues at the local level. Public Health Ontario (PHO) leads the Community Opioid / Overdose Capacity Building (COM-CAP) project, which aims to reduce overdose-related harms at the community level by working with communities to identify, develop, and evaluate capacity building supports for local needs around overdose planning. The 'From Design to Action' co-design workshop used a participatory design approach to engage communities in identifying the requirements for capacity building support.
View Article and Find Full Text PDFCan J Anaesth
May 2023
Department of Anesthesiology & Pain Medicine, University of Toronto, Toronto, ON, Canada.
Pilot Feasibility Stud
August 2022
Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Background: Oral anticoagulants (OACs) are commonly prescribed, have well-documented benefits for important clinical outcomes but have serious harms as well. Rates of OAC-related adverse events including thromboembolic and hemorrhagic events are especially high shortly after hospital discharge. Expert OAC management involving virtual care is a research priority given its potential to reach remote communities in a more feasible, timely, and less costly way than in-person care.
View Article and Find Full Text PDFBMC Public Health
July 2022
Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, M5G 1V2, Canada.
Background: Many communities across North America are coming together to develop comprehensive plans to address and respond to the escalating overdose crisis, largely driven by an increasingly toxic unregulated drug supply. As there is a need to build capacity for successful implementation, the objective of our mixed methods study was to identify the current planning and implementation practices, needs, and priority areas of support for community overdose response plans in Ontario, Canada.
Methods: We used a situational assessment methodology to collect data on current planning and implementation practices, needs, and challenges related to community overdose response plans in Ontario, consisting of three components.
Can Pharm J (Ott)
August 2020
Institute for Safe Medication Practices Canada (Kong, Chiu, Ho), Toronto, Ontario.
Objectives: Inpatient hospital pharmacies have a central role in managing controlled substances (CS) throughout the hospital medication use process (MUP). Our objectives were to identify vulnerabilities for diversion in the MUPs of 2 inpatient pharmacies, explore differences between the sites, and characterize the types of vulnerabilities identified.
Methods: We conducted clinical observations in 2 pharmacies to map their MUPs and performed a healthcare failure mode and effect analysis to proactively identify (1) the critical failure modes (CFMs) that make them vulnerable to diversion and (2) the controls that prevent, mitigate, or enhance the detectability of CFMs.
PLoS One
September 2020
Bridgepoint Collaboratory for Research and Innovation, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Context: Opioid related deaths are at epidemic levels in many developed nations globally. Concerns about the contribution of prescribed opioids, and particularly high-dose opioids, continue to mount as do initiatives to reduce prescribing. Evidence around opioid tapering, which can be challenging and potentially hazardous, is not well developed.
View Article and Find Full Text PDFCMAJ Open
February 2021
HumanEra (Fan, Trbovich), Office of Research and Innovation, North York General Hospital; Institute for Safe Medication Practices Canada (Tscheng, Hamilton); Institute of Health Policy, Management and Evaluation (Trbovich), University of Toronto, Toronto, Ont.
Background: Canadian health care facilities must report losses or thefts of opioids to Health Canada. To broaden the understanding of opioid loss in Canada, we analyzed data describing these losses to estimate the amount of opioid lost, estimate the wholesale and street value, compare the distribution of loss types between facility types and compare loss trends.
Methods: We analyzed Health Canada records of losses of codeine, fentanyl, hydromorphone, morphine and oxycodone reported by Canadian facilities from January 2012 to September 2017.
Can J Hosp Pharm
December 2019
, BSc(Pharm), RPh, is with the Institute for Safe Medication Practices Canada, Toronto, Ontario.
Background: Discharge medication reconciliation (MedRec) is designed to reduce medication errors and inform patients and key postdischarge providers, but it has been difficult to implement routinely in Canadian hospitals.
Objectives: To evaluate and optimize a new discharge MedRec quality audit tool and to use it at 3 urban teaching hospitals.
Methods: The discharge MedRec quality audit tool, developed by the Canadian Patient Safety Institute and the Institute for Safe Medication Practices Canada, was assessed and modified to improve comprehensiveness, clarity, and quality.
BMJ Open
June 2019
HumanEra, Research and Innovation, North York General Hospital, Toronto, Ontario, Canada.
Introduction: An increasing number of opioids and other controlled substances are being stolen from healthcare facilities, diverting medications from their intended medical use to be used or sold illicitly. Many incidents of medication loss from Canadian hospitals are reported as unexplained losses. Together, this suggests not only that vulnerabilities for diversion exist within current medication-use processes (MUPs), but that hospitals lack robust mechanisms to accurately track and account for discrepancies and loss in inventory.
View Article and Find Full Text PDFJ Hosp Med
July 2019
HumanEra, Office of Research and Innovation, North York General Hospital, Toronto, Ontario, Canada.
Drug losses and theft from the healthcare system are accelerating; hospitals are pressured to implement safeguards to prevent drug diversion. Thus far, no reviews summarize all known risks and potential safeguards for hospital diversion. Past incidents of hospital drug diversion have impacted patient and staff safety, increased hospital costs, and resulted in infectious disease outbreaks.
View Article and Find Full Text PDFCrit Care Med
July 2019
HumanEra, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Objectives: Assess interventions' impact on preventing IV infusion identification and disconnection mix-ups.
Design: Experimental study with repeated measures design.
Setting: High fidelity simulated adult ICU.
Policy Polit Nurs Pract
August 2019
Nursing Practice and Policy, Canadian Nurses Association, Ottawa, ON, Canada.
Canada's legalization of Medical Assistance in Dying (MAiD) in 2016 has had important implications for nursing regulators. Evidence indicates that registered nurses perform key roles in ensuring high-quality care for patients receiving MAiD. Further, Canada is the first country to recognize nurse practitioners as MAiD assessors and providers.
View Article and Find Full Text PDFCMAJ Open
December 2018
Leslie Dan Faculty of Pharmacy (Boucher, Ho), University of Toronto; Institute for Safe Medication Practices Canada (Boucher, Ho), Toronto, Ont.; James L. Winkle College of Pharmacy (MacKinnon), University of Cincinnati, Cincinnati, OH; Gerald Schwartz School of Business (Boyle), St. Francis Xavier University, Antigonish, NS; IWK Health Centre (Bishop); Rowe School of Business (Gonzalez, Barker), and Department of Business and Social Science (Hartt), Dalhousie University, Halifax, NS.
Background: Quality-related events are defined as medication errors that reach the patient (e.g., incorrect drug, dose and quantity), in addition to medication errors that are intercepted before dispensing (i.
View Article and Find Full Text PDFCan Pharm J (Ott)
May 2018
Cancer Care Ontario (Vu), Toronto.
J Oncol Pharm Pract
April 2019
4 Canadian Association of Provincial Cancer Agencies (CAPCA), Toronto, Ontario, Canada.
Purpose: To create a set of consensus-based and evidence-informed recommendations to provide guidance around the safe dispensing and handling of oral anti-cancer drugs in low-volume settings unique to the community pharmacy setting.
Methods: A review of published and grey literature (published in non-commercial domains such as national organizations and associations) documents and nine key informant interviews were conducted and a modified Delphi approach was taken to achieve consensus. The final list of 47 candidate recommendations was reviewed by a task force and validated by multi-disciplinary stakeholders.
BMJ Open
April 2017
Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.
Introduction: In North America, drug overdose deaths are reaching unprecedented levels, largely driven by increasing prescription opioid-related deaths. Despite the development of several opioid guidelines, prescribing behaviours still contribute to poor patient outcomes and societal harm. Factors at the provider and system level may hinder or facilitate the application of evidence-based guidelines; interventions designed to address such factors are needed.
View Article and Find Full Text PDFCMAJ Open
March 2017
Office of the Chief Coroner for Ontario (Lowe), Toronto, Ont.; Institute for Safe Medication Practices Canada (Hamilton, Greenall, Ma); St. Michael's Hospital, Health Quality Ontario and Department of Medicine and Institute for Health Policy, Management and Evaluation, University of Toronto (Dhalla); Department of Family and Community Medicine, St. Michael's Hospital, and Department of Family and Community Medicine, University of Toronto (Persaud), Toronto, Ont.
Background: Opioids have narrow therapeutic windows, and errors in ordering or administration can be fatal. The purpose of this study was to describe deaths involving hydromorphone and morphine, which have similar-sounding names, but different potencies.
Methods: In this case series, we describe deaths of patients admitted to hospital or residents of long-term care facilities that involved hydromorphone and morphine.
Am J Health Syst Pharm
November 2016
Women's College Research Institute, Toronto, Canada.
Purpose: The published literature on medication reconciliation (MR) interventions, outcomes, and facilitators in ambulatory care settings is reviewed.
Methods: A scoping review was conducted to characterize ambulatory care-based MR research in terms of study design, elements of interventions, and outcomes examined. English-language articles on comparative studies of MR programs targeting adults in ambulatory care settings were identified using data sources including MEDLINE, PreMEDLINE, EMBASE, and International Pharmaceutical Abstracts.
Can J Hosp Pharm
September 2016
, BSc, is with the Children's Hospital of Eastern Ontario, Ottawa, Ontario.
Background: Inherent risks are associated with the preparation and administration of medications. As such, a key aspect of medication safety is to ensure safe medication management practices.
Objective: To identify key medication safety issues and high-alert drug classes that might benefit from implementation of pictograms, for use by health care providers, to enhance medication administration safety.
BMJ Qual Saf
May 2017
Institute for Safe Medication Practices Canada, Toronto, Ontario, Canada.